Your browser doesn't support javascript.
loading
GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance.
Kuang, Ruby; Jahangiri, Arman; Mascharak, Smita; Nguyen, Alan; Chandra, Ankush; Flanigan, Patrick M; Yagnik, Garima; Wagner, Jeffrey R; De Lay, Michael; Carrera, Diego; Castro, Brandyn A; Hayes, Josie; Sidorov, Maxim; Garcia, Jose Luiz Izquierdo; Eriksson, Pia; Ronen, Sabrina; Phillips, Joanna; Molinaro, Annette; Koliwad, Suneil; Aghi, Manish K.
Afiliação
  • Kuang R; Department of Neurological Surgery.
  • Jahangiri A; Department of Neurological Surgery.
  • Mascharak S; Department of Neurological Surgery.
  • Nguyen A; Department of Neurological Surgery.
  • Chandra A; Department of Neurological Surgery.
  • Flanigan PM; Department of Neurological Surgery.
  • Yagnik G; Department of Neurological Surgery.
  • Wagner JR; Department of Neurological Surgery.
  • De Lay M; Department of Neurological Surgery.
  • Carrera D; Department of Neurological Surgery.
  • Castro BA; Department of Neurological Surgery.
  • Hayes J; Department of Neurological Surgery.
  • Sidorov M; Department of Neurological Surgery.
  • Garcia JLI; Department of Radiology.
  • Eriksson P; Department of Radiology.
  • Ronen S; Department of Radiology.
  • Phillips J; Department of Neuropathology, and.
  • Molinaro A; Department of Neurological Surgery.
  • Koliwad S; Diabetes Center, University of California at San Francisco, San Francisco, California, USA.
  • Aghi MK; Department of Neurological Surgery.
JCI Insight ; 2(2): e88815, 2017 01 26.
Article em En | MEDLINE | ID: mdl-28138554
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma / Resistencia a Medicamentos Antineoplásicos / Inibidores da Angiogênese / Transportador de Glucose Tipo 3 / Bevacizumab / Glicólise Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma / Resistencia a Medicamentos Antineoplásicos / Inibidores da Angiogênese / Transportador de Glucose Tipo 3 / Bevacizumab / Glicólise Idioma: En Ano de publicação: 2017 Tipo de documento: Article